ATOSSA THERAPEUTICS INC (ATOS)
US04962H5063 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -30.09M | -26.96M | -20.61M | -17.83M | -17.24M | |||
| Depreciation Amortization | 23.00K | 10.00K | 20.00K | 50.00K | 50.00K | |||
| Change In Working Capital | 776.00K | -930.00K | -720.00K | -220.00K | -570.00K | |||
| Interest Paid | N/A | N/A | N/A | N/A | N/A | |||
| Other non cash items | 8.35M | 7.12M | 4.83M | 6.43M | 8.63M | |||
| OPERATING CASH FLOW | -20.94M | -20.76M | -16.47M | -11.57M | -9.13M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -14.00K | -30.00K | -10.00K | -10.00K | -10.00K | |||
| Other Investing Activity | 0.00 | -4.70M | N/A | N/A | N/A | |||
| INVESTING CASH FLOW | -14.00K | -4.73M | -10.00K | -10.00K | -10.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | N/A | N/A | N/A | |||
| Stock Issued/Repurchased | -1.48M | 0.00 | 113.30M | 38.55M | 11.34M | |||
| FINANCING CASH FLOW | -1.48M | 0.00 | 113.30M | 38.55M | 11.34M | |||
| CHANGE IN CASH | -22.43M | -25.49M | 96.82M | 26.97M | 2.20M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -20.94M | -20.76M | -16.47M | -11.57M | -9.13M | |||
| Capital Expenditure | -14.00K | -30.00K | -10.00K | -10.00K | -10.00K | |||
| FREE CASH FLOW | -20.95M | -20.79M | -16.48M | -11.58M | -9.14M | |||
All data in USD